130 related articles for article (PubMed ID: 7713920)
1. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells.
Ehlers M; de Hon FD; Bos HK; Horsten U; Kurapkat G; van De Leur HS; Grötzinger J; Wollmer A; Brakenhoff JP; Rose-John S
J Biol Chem; 1995 Apr; 270(14):8158-63. PubMed ID: 7713920
[TBL] [Abstract][Full Text] [Related]
2. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
[TBL] [Abstract][Full Text] [Related]
3. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.
de Hon FD; Ehlers M; Rose-John S; Ebeling SB; Bos HK; Aarden LA; Brakenhoff JP
J Exp Med; 1994 Dec; 180(6):2395-400. PubMed ID: 7964514
[TBL] [Abstract][Full Text] [Related]
4. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.
Savino R; Lahm A; Salvati AL; Ciapponi L; Sporeno E; Altamura S; Paonessa G; Toniatti C; Ciliberto G
EMBO J; 1994 Mar; 13(6):1357-67. PubMed ID: 7511100
[TBL] [Abstract][Full Text] [Related]
5. Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130.
de Hon FD; ten Boekel E; Herrman J; Clement C; Ehlers M; Taga T; Yasukawa K; Ohsugi Y; Kishimoto T; Rose-John S
Cytokine; 1995 Jul; 7(5):398-407. PubMed ID: 7578977
[TBL] [Abstract][Full Text] [Related]
6. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
[TBL] [Abstract][Full Text] [Related]
7. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
Kovacs E
Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
[TBL] [Abstract][Full Text] [Related]
8. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
[TBL] [Abstract][Full Text] [Related]
9. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor.
Horsten U; Schmitz-Van de Leur H; Müllberg J; Heinrich PC; Rose-John S
FEBS Lett; 1995 Feb; 360(1):43-6. PubMed ID: 7875298
[TBL] [Abstract][Full Text] [Related]
10. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
Li H; Nicholas J
J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
[TBL] [Abstract][Full Text] [Related]
14. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.
Paonessa G; Graziani R; De Serio A; Savino R; Ciapponi L; Lahm A; Salvati AL; Toniatti C; Ciliberto G
EMBO J; 1995 May; 14(9):1942-51. PubMed ID: 7744001
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease.
Rodriguez C; Theillet C; Portier M; Bataille R; Klein B
FEBS Lett; 1994 Mar; 341(2-3):156-61. PubMed ID: 8137932
[TBL] [Abstract][Full Text] [Related]
16. A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor.
Dittrich E; Haft CR; Muys L; Heinrich PC; Graeve L
J Biol Chem; 1996 Mar; 271(10):5487-94. PubMed ID: 8621406
[TBL] [Abstract][Full Text] [Related]
17. Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
Sporeno E; Savino R; Ciapponi L; Paonessa G; Cabibbo A; Lahm A; Pulkki K; Sun RX; Toniatti C; Klein B; Ciliberto G
Blood; 1996 Jun; 87(11):4510-9. PubMed ID: 8639818
[TBL] [Abstract][Full Text] [Related]
18. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
19. Leucine-58 in the putative 5th helical region of human interleukin (IL)-6 is important for activation of the IL-6 signal transducer, gp130.
de Hon FD; Klaasse Bos HK; Ebeling SB; Grötzinger J; Kurapkat G; Rose-John S; Aarden LA; Brakenhoff JP
FEBS Lett; 1995 Aug; 369(2-3):187-91. PubMed ID: 7649255
[TBL] [Abstract][Full Text] [Related]
20. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
Graeve L; Korolenko TA; Hemmann U; Weiergräber O; Dittrich E; Heinrich PC
FEBS Lett; 1996 Dec; 399(1-2):131-4. PubMed ID: 8980136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
